top of page
[[STOCK IMAGE]]earth3.jpeg


The human spaceflight sector is growing rapidly, with commercial space companies poised to be the primary driver of human spaceflight activity by 2040 and NASA’s focus on space exploration taking on a new dimension. Under the Artemis program, NASA is focused on returning humans to the Moon and establishing sustainable lunar operations as a foundation for future deep space missions. These missions present new challenges and a new opportunity to expand the field of players working to solve the health and performance risks in human spaceflight.


Starburst Aerospace (Starburst), NASA’s Human Research Program (NASA HRP), the Translational Research Institute for Space Health (TRISH), and Microsoft Federal (Microsoft) have come together to support entrepreneurs working to advance biological and medical capabilities that have to potential to minimize the health and performance risks in human spaceflight.

SPACE-H Topic Areas

For the inaugural year of Space-H, the focus will be on resilient, autonomous health and performance systems. In support of Artemis and future deep space exploration, NASA is seeking commercial partners to support the development of fully autonomous, integrated medical systems to monitor and manage the health of individuals and teams.

AI for System-level Autonomy - Fully autonomous, multi-modal systems to model risks, predict outcomes, and prioritize actions while far from Earth

Synthetic Data - Statistically equivalent synthesized data sets for testing data integration and outputs that can be used in place of sensitive astronaut data

Computational Biology - Solutions to understand the effects of molecular damage on biological systems, assess long-term risks, and enable precise/personalized medical care

Medical Devices - Compact, lightweight, efficient, multifunctional medical devices to enable every day and medical emergencies

Sensors - Highly capable sensors that monitor environmental and physiological health, cognitive health and crew performance, sleep quality and activity levels, and sensorimotor adaptation to changes in gravity

Pharmaceuticals - Novel solutions for manufacturing pharmaceuticals in the space environment

Biomedical Technologies - Technologies to model diseases, test drug toxicity and response, and predict efficacy of treatments

For more detailed descriptions of the topics listed, see overview.

2024 SPACE-H Program Timeline

bottom of page